A newly published and very detailed paper based on data from the PRACTICAL consortium now seems to have confirmed that taller men are at greater risk for high-risk prostate cancer than shorter ones (like your sitemaster). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: gene, grade, growth, Height, risk | 1 Comment »
This is by no means the first time it has been suggested that taller men and women are at greater risk for cancer than shorter ones, but such data will again be presented at an ongoing meeting of the European Society of Paediatric Endocrinology in Barcelona, Spain. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, Height, risk | 1 Comment »
The “New” Prostate Cancer InfoLink has been pointing out (on a fairly regular basis over the past 5 years) that at least some of our risk for prostate cancer (other than the genetic risks) may be affected by what happens to us in childhood. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: age, childhood, diet, Height, risk, weight | 4 Comments »
According to a poster recently presented at a South-Eastern Section meeting of the American Urology Association, there is a significant and independent relationship between male height and risk for biochemical recurrence after radical surgery as a treatment for prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Height, recurrence, risk, surgery | 6 Comments »
Apparently Ferring Pharmaceuticals has finally been able to get Firmagon® approved as the new trade (brand) name for degarelix (their new LHRH antagonist) here in the USA. This is the same brand name as is used in Europe. Who knows why it took so long! The media release doesn’t say.
In other news reports today we comment on studies dealing with:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: Degarelix, Height, quality of care, survival, tallness, vitamin B-6 | Leave a comment »
Based on a recent British study, media reports are suggesting that, “Taller men are at greater risk for prostate cancer and more likely to have cancer that progresses quickly.” However, The “New” Prostate Cancer InfoLink suspects that height itself is not the issue. Rather, height may serve as a marker for something biological associated with risk for developing cancer. And even so, this risk is small by comparison with more evident risks such as race, age, and family history. … READ MORE …
Filed under: Diagnosis | Tagged: cancer, Height, prostate, risk | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 